MORE►
life sciences
Chip Register, CEO of Argano [Photo: Argano]
Plano’s Argano Acquires Life Sciences-Focused Pharosity Consulting
by Sandra Engelland | Jan 27, 2026
"This acquisition supports our continued focus on delivering AI-enabled high-performance operations for pharmaceutical organizations facing increasingly complex regulatory and data environments,” said Chip Register, Group CEO of Argano.
by Maddie Preston |
Dec 23, 2025
A new satellite campus is adding hands-on training, lab capacity and startup support to Dallas’ growing life sciences ecosystem.
MORE►
![Anthony Milonas, CEO of Alliance Clinical Network. [Photo: LinkedIn]](https://s24806.pcdn.co/wp-content/uploads/2025/11/AllianceClinicalNetwork_AnthonyMilonas-970-1-360x203.jpg)
by Sandra Engelland |
Nov 20, 2025
Anthony Milonas brings more than two decades of experience leading and scaling multi-site healthcare organizations across North America.
MORE►
by Nicole Ward, DRC Data Journalist |
Nov 11, 2025
With a new Dallas headquarters and the recent acquisition of Cairo Diagnostics, Sonic Healthcare USA is expanding its reach and speeding access to advanced cancer testing.
MORE►
John Crowley, CEO of the Biotechnology Innovation Organization; Texas State Sen. Tan Parker; and Victoria Ford, CEO of the Texas Healthcare and Bioscience Institute, were among the voices shaping the conversation at the 2025 BioNTX iC3 Summit in Dallas. [Photos: Courtesy/BioNTX]
‘The Model is Broken’: From North Texas, a National Call to Action for Biotech’s Future
by Glenn Hunter | Sep 24, 2025
At Dallas’ iC3 Summit, leaders from Texas and across the U.S. pointed to AI, new state initiatives like Proposition 14, and potential federal reforms as keys to speeding innovation and keeping America competitive in life sciences.
MORE►
by Lance Murray |
Aug 28, 2025
The Pittsburgh-headquartered nonprofit's executive director, Dallas-based Gina Ford, takes up the newly created top post of the organization, which empowers women across biotech, pharma, and life sciences to lead, engage, and grow at every career stage.
MORE►
by David Seeley |
Jul 15, 2025
The California-based clinical-stage biotech startup is developing therapies to treat serious immunological diseases like atopic dermatitis and vitiligo.
MORE►
by Nicole Ward, DRC Data Journalist |
Apr 3, 2025
Startup culture, higher ed, advanced tech, and quality of life drew them in—but what kept them here is more personal. Meet the 10 transplants who now call North Texas home. As one newcomer put it: “We’re living our best life in Texas.”
MORE►
Pegasus artwork in the lobby of Dallas' Pegasus Park, the home of the ARPA-H Customer Experience Hub. [Photo: Dallas Innovates]
The Last Word: Dallas Tops Site Selection’s Metro Rankings, ‘Double Shot’ of Life Sciences Investment Adds to Momentum
by Quincy Preston | Mar 5, 2024
According to a new report from Dallas-based JLL, society is accelerating the volume of data it creates at a rapid rate—and that data is foundational to how we work, live, and play. That's led to sharply increasing demand for data centers in a time of tightening supply, forcing a shift toward secondary and new, emerging markets.
MORE►
by Quincy Preston |
Sep 1, 2023
Tarleton State University received the go-ahead for a new biotechnology institute as part of Texas A&M-Fort Worth’s burgeoning downtown research campus.
Approved in mid-August by the Texas A&M University System Board of Regents, the biotech institute is situated in one of the nation’s fastest-growing life sciences hubs....
MORE►
by Dallas Innovates | Staff Report |
Jul 28, 2023
“Delivering these projects will help to increase the speed-to-market and meet the overwhelming demand for new medicines," said Richard Meserole, president of Fluor’s advanced technologies and life sciences business.
MORE►
by Lance Murray |
Jun 15, 2023
The $110 million, 135,000 square-foot expansion at Pegasus Park—a regional hub for life sciences and biotechnology in North Texas—will offer prebuilt lab suites with the tools and flexible space needed for growth-stage life sciences entrepreneurs and companies. Demolition is underway and construction on Bridge Labs is set to begin soon, developers said.
MORE►
ConcertAI CEO Jeff Elton (left) and David Spetzler, president of Caris Life Sciences [Photo: ConcertAI]
Caris Life Sciences and ConcertAI Announce New Clinico-Genomic Research Platform
by Lance Murray | Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Lance Murray |
Mar 15, 2023
Dallas-based growth-oriented private equity firm Trinity Hunt Partners announced a majority investment in Supreme Optimization, a digital marketing agency focused exclusively on life sciences.
No financial details were released....
MORE►
by Lance Murray |
Feb 7, 2023
Dallas-based alternative investment firm NexPoint has revealed details and renderings of its planned 200-acre TxS District, short for "Technology x Science." Centered on the former headquarters campus of EDS in Plano's Legacy development, the life sciences hub could eventually offer over 4 million square feet of lab, office, and therapeutic production space.
"Not only would this project be a major economic catalyst for the region, but it would also establish North Texas as a leader in life sciences," says James Dondero, NexPoint founder and principal.
MORE►
by Lance Murray |
Dec 2, 2022
Dallas-based life science company ReCode Therapeutics has appointed Patricia “Trisha” Millican to its board of directors, bringing with her more than 20 years of experience in the life science industry....
MORE►
